PRESS: OPEN CALL: The International Bureau for Epilepsy, and UCB announce the III International Journalism Award
BRUSSELS, May 17, 2011 / PRNewswire / - The International Bureau for Epilepsy (IBE) and the biopharmaceutical company UCB have summoned the Third International Epilepsy Journalism Award 2011. This award is a joint initiative to raise awareness about epilepsy in the entire world, by recognizing journalists who have excelled in the spread of this disease.
Epilepsy is the most common serious neurological disease among the population that currently affects nearly 50 million people worldwide1. Since its premiere in 2009, the International Epilepsy Journalism Award has recognized those articles most original and best documented about epilepsy and, year after year, has been attracting a growing number of high level participants from around the world , getting attention about a subject very little attention in the media, such as epilepsy.
The International Epilepsy Journalism Award is open to journalists from around the world who can present their own work or be nominated by others. The competition comprises three categories (press, radio and online and Radio / Television), in which they choose a winner for each of them. Nominations shall be evaluated by an independent panel of media experts and people involved with the world of epilepsy. The jurors will consider the journalistic based on objectivity, documentation, originality and ability to improve knowledge and awareness about epilepsy. Entries can be on any aspect related to the disease and must have been published or broadcast between October 30, 2010 and November 30, 2011.
Notes to editors
participation criteria
For this event in greater depth or to download the entry form, please visit: http://www.ibe-epilepsy.org/downloads/Award% 20Form% 20Web% 202011.pdf
Depending on the country could apply some local restrictions on the award, and it would only be available in countries where not prohibited or restricted by local regulations.
About the International Bureau for Epilepsy (IBE)
Founded nearly 50 years ago, the International Bureau for Epilepsy - IBE according to its acronym in English (International Bureau for Epilepsy ) is an organization formed by professionals and amateurs who are interested in the medical aspects and not Medical epilepsy. The IBE addresses such social issues as education, employment, insurance, constraints in obtaining a driver's license and awareness by the population. In addition, supports its members through initiatives to improve the quality of life of people with epilepsy and their families. http://www.ibe-epilepsy.org
About UCB
UCB, Brussels, Belgium is a biopharmaceutical company engaged in the research, development and commercialization of innovative medicines focused on two therapeutic areas: system CNS and immunology.
future Claims
This press release contains forward-looking statements based on current plans, estimates and current management methods. Such statements are subject to risk factors and uncertainties that could cause actual results to be realized differently from that expressed in this press release. Among the factors that could cause such differences include: changes in general economic, business and competitive conditions, effects of future judicial decisions, regulatory changes, fluctuations in the bag recruitment and retention of employees.
References
1. http://www.who.int/mediacentre/factsheets/fs999/ in / [updated on March 7, 2011] CONTACT: For more information: IBE, Ann Little, Executive Director, IBE, T +353-1-210-8850, ibedublin@eircom.net , UCB, Nancy Nackaerts, External Communications, UCB, T +32-473-864-414, nancy.nackaerts @ ucb.com , Eimear O'Brien, Associate Director, Global CNS Communications UCB T +32-2-559-9271, eimear.obrien @ ucb.com
http://noticias.terra.es/2011/mundo/0517/actualidad/comunicado-convocatoria-abierta- the-office-international-for-epilepsy-and-ucb-summon-the-iii-award-journalistic-intern.aspx
0 comments:
Post a Comment